CU researchers announce new technique for rapidly detecting illness-causing bacteria in foodJuly 19, 2005NEW ORLEANS - Cornell University scientists have developed a rapid, less costly and sensitive new technique for detecting group A streptococcus, the bacteria that cause scarlet fever. Details will be announced today at the Institute of Food Technologists Annual Meeting and Food Expo in New Orleans. The presentation by Sam Nugen, a graduate student in Cornell's food science department, will focus on detecting the food-borne bacteria Streptococcus pyogenes (S. pyogenes), but the technique can be applied to a wide variety of bacterial pathogens, including Escherichia coli (E. coli). The new biosensor works in a test tube and a positive result shows up as a red line on a strip, much like a pregnancy test. Newly designed software gives researchers a powerful tool for increasing the sensitivity of the analysis.
The method may help researchers and companies that are in the business of tracking food-borne pathogens, allowing technicians to determine a source quickly. It may also help to analyze a throat culture swab, to tell if someone has an illness like strep throat. "We hope to see this technique commercialized, because it is very rapid compared to all the standard methods right now," said Nugen, the study's lead author. Nugen conducted his research in the laboratory of Antje Baeumner, Cornell associate professor of biological and environmental engineering, who is also a co-author of the study. "It would be great if we came up with something that became a standard," Nugen added. Current biosensors rely on a time-consuming technique called gene amplification that requires costly equipment: Technicians take a piece of DNA from a sample and add enzymes that make many copies of the DNA. Duplicating or "amplifying" the DNA makes a pathogen easier to detect. The new process starts with genetic material that is extracted from a food sample. This material, called ribosomal RNA (rRNA), is responsible for translating genetic information carried in DNA into proteins. Nugen designed the computer software that allows researchers to enter in an rRNA sequence, called a target sequence, that is unique to a specific microbe. The program then determines tiny sequences of complementary DNA - known as probes - that are exactly matched to stick to the rRNA target sites. These sequences are then reproduced as genetic material by a biotech company. To test for the presence of scarlet fever-causing bacteria, a sample of rRNA is placed in a test tube with two of the manufactured probe DNA sequences, designed specifically to bind to the rRNA of S. pyogenes. One of these is called a "capture" probe, and the other is known as a "reporter" probe. The capture probe binds to the S. pyogenes rRNA and anchors it to a zone on a strip of membrane, while the reporter probe, which has a dye attached to it, sticks to another sequence of the S. pyogenes rRNA. The probes attach to the target rRNA sequence when the test tube is placed in a water bath for about 25 minutes at exactly 41 degrees Celsius (106 Fahrenheit). At that temperature, the complementary probe DNA sequence binds to the target RNA sequences. In a positive result, the capture probe attached to the rRNA target molecule anchors itself to a strip on a membrane. Since the reporter probe with a red dye is also attached to the rRNA molecule, as the material collects on a zone on the membrane, it turns the strip visibly red, much like with a pregnancy test. The entire process takes only 35 minutes, while traditional gene amplification techniques may take many hours. Promising early results suggest the sensitive method could detect fewer than 100 cells of a pathogen in just half an hour. Nugen's software also compares a target site with sequences from other organisms to make sure they don't overlap, which could lead to a misdiagnosis. "You want to be sure it doesn't detect another organism that shares similar properties," said Nugen. The study was funded by the National Institutes of Health. Along with Baeumner, Barbara Leonard, a research support specialist in Cornell's biological and environmental engineering department, was also a co-author. Cornell University | |||||||||||||||||||||
|
Related Streptococcus Current Events and Streptococcus News Articles Probiotic bacteria can induce monocyte-derived dendritic cells maturation? Probiotic bacteria are widely used to relieve the symptoms of many disorders such as inflammatory bowel syndrome, diarrhea, and allergies. Probiotic mixtures have also been found to reduce the symptoms of diarrhea. New approach to treating cystic fibrosis lung infection shows promise Researchers at the University of Calgary have found a new method of fighting severe lung infections in people with cystic fibrosis (CF). These findings are published in Proceedings of the National Academy of Science USA, this week. New insights could lead to a better pneumococcal vaccine Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH). Bleeding gums linked to heart disease Bad teeth, bleeding gums and poor dental hygiene can end up causing heart disease, scientists heard today (Thursday 11 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin. How flesh-eating bacteria attack the body's immune system "Flesh-eating" or "Strep" bacteria are able to survive and spread in the body by degrading a key immune defense molecule, according to researchers at the University of California, San Diego, School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences. From foe to friend: Researchers use salmonella as a way to administer vaccines in the body Researchers at the Biodesign Institute at Arizona State University have made a major step forward in their work to develop a biologically engineered organism that can effectively deliver an antigen in the body. The researchers report that they have been able to use live salmonella bacterium as the containment/delivery method for an antigen. Despite vaccine, public should not get complacent about pneumococcal disease Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston. Ashwell receptor reduces mortality during sepsis In research that solves the longest-standing mystery in glycobiology - a field that studies complex sugar chains called glycans - researchers at the University of California, San Diego School of Medicine have discovered that a molecule in the liver of all animals, called the Ashwell receptor, is critical in helping the body fight off the abnormal and lethal blood clotting caused by bacterial infection. Research could put penicillin back in battle against antibiotic resistant bugs that kill millions Research led by the University of Warwick has uncovered exactly how the bacterium Streptococcus pneumoniae has become resistant to the antibiotic penicillin. The same research could also open up MRSA to attack by penicillin and help create a library of designer antibiotics to use against a range of other dangerous bacteria. Microscopic 'astronauts' to go back in orbit When space shuttle Endeavor blasts off on March 11, some tiny 'astronauts' will piggyback onboard an experimental payload from Arizona State University's Biodesign Institute. More Streptococcus Current Events and Streptococcus News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||